ArticleOncotarget2017
Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients.
Chieh-Sheng Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleOncotarget2017
Chieh-Sheng Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.